Labshake search
Citations for R&D Systems :
701 - 750 of 2683 citations for Recombinant Human Long Arg3 Insulin like Growth Factor I since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2021Quote: The following recombinant proteins and drugs were purchased: human/mouse WNT5A (654-WN-010, R&D Systems); Wnt-C59 (C7641-2s ...
-
bioRxiv - Cell Biology 2022Quote: ... Cells were then treated with 10 ng/ml of recombinant human EGF (236-EG, R&D systems) in RPMI-1640 medium and incubated at 37℃ ...
-
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingbioRxiv - Cell Biology 2022Quote: ... then treated with 20-25 ng/ml recombinant human BMP4 protein (R&D Systems, Cat# 314-BP). For acetylcholine receptor clustering experiments ...
-
bioRxiv - Immunology 2022Quote: ... 1% PS and 100 IU/ml of human recombinant IL-2 (R&D Systems, 202-IL-050). Cells were used at low passage numbers ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... Recombinant human IL-1β was obtained from R&D Systems (Abingdon, UK; Cat. No. 201-LB/CF) and recombinant murine IFNγ from PeproTech (Rocky Hill ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant Human IL-27 Ra/WSX-1/TCCR Fc Chimera Protein (2 μg/ml, R&D Systems), Ultrapure LPS from E ...
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Cell Biology 2022Quote: ... 48 and 96 hours in the presence or absence of recombinant human IL-1β (R&D systems), recombinant human IFNγ (PeproTech ...
-
bioRxiv - Cancer Biology 2022Quote: ... unconditioned HEI-193 media supplemented with recombinant human CCL21 600 ng/ml (366-6C, R&D Systems) as a positive control ...
-
bioRxiv - Immunology 2023Quote: ... The signals were compared to a standard curve generated with recombinant human IL-21 (R&D Systems).
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant HGF (R&D Systems). After 14 to 24 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... recombinant human IL-4 500 IU/mL and GM- CSF 800 IU/mL (both R&D systems) at a cell density of 1-2 x106 cells/mL for 5 days ...
-
bioRxiv - Microbiology 2024Quote: 107 parasites were incubated with 0.5 μg recombinant human IgG Fc (R&D Systems, cat# 110-HG) or recombinant CD36-Fc (R&D Systems ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human interferon-γ protein (Cat. #285-IF, lot #RAX2422031, R&D Systems, Minneapolis, Minnesota, United States), Pierce streptavidin poly-horseradish peroxidase (pHRP ...
-
bioRxiv - Cancer Biology 2020Quote: Twenty thousand HUVEC cells were seeded in reduced growth factor basement membrane extract (BME)-coated 96-well plate (R&D systems: 3470-096-K). Endothelial cells were exposed to 100 μl of the different benign or malignant cells conditioned media ...
-
bioRxiv - Neuroscience 2022Quote: ... were grown in their undifferentiated form on 20ug/mL Cultrex reduced growth factor basement membrane (catalog number 3433, R&D Systems, Minneapolis, Minnesota, USA) in DMEM/F12 (catalog number 11320033 ...
-
bioRxiv - Immunology 2023Quote: ... and 50 μg/ml L-Ascorbic Acid)) supplemented with Growth Factor Cocktail (5 ng/ml BMP4, 5 ng/ml bFGF, 10 ng/ml IL-6 (R&D systems, 206-IL), 10 ng/ml Flt3L (PeproTech ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with 3 uM CHIR, 300 nM LDN193189 (LDN, Axon, Scottsdale, AZ) and 100 ng/mL epidermal growth factor (EGF, R&D systems, Minneapolis, MN) in Advanced DMEM/F12 (Invitrogen ...
-
bioRxiv - Cancer Biology 2020Quote: ... mouse or rat collagen I (human, R&D Systems; mouse, Ray Biotech; rat, Yo Protein) or collagen III (human ...
-
bioRxiv - Immunology 2020Quote: ... and 10 ng/mL of human macrophage colony stimulating factor (M-CSF, R&D Systems, catalog number 216-MC) for at least 10 days to generate mature macrophages before use in experiments.
-
bioRxiv - Immunology 2023Quote: ... Supernatants were collected and analyzed for the presence of secreted factors using Luminex human Discovery Assays (R&D Systems): LXSAHM-02 (MMP-8) ...
-
bioRxiv - Neuroscience 2020Quote: ... L-glutamine and 10 ng/ml of carrier-free murine recombinant granulocyte and macrophage colony-stimulating factor (GM-CSF, 415-ML, R&D systems, Minneapolis, MN). Cell suspension from one brain was plated in a T75-cell culture flask coated with poly-D-lysine (P7280 ...
-
bioRxiv - Microbiology 2023Quote: ... and 50 mmol/L β-mercaptoethanol] supplemented with recombinant mouse stem cell factor (SCF) (12.5 ng/mL; R&D Systems, Cat. No. 455-MC) and recombinant mouse IL-3 (10 ng/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Cell Biology 2022Quote: ... hMEC 3D acini were resuspended in 10 mg/ml Cultrex Reduced Growth Factor Basement Membrane Extract (BME) Type 2 (R&D Systems, #3532-005-02) and 25 μl BME domes were plated in each well of µ-Slides 8 (Ibidi) ...
-
bioRxiv - Microbiology 2023Quote: ... organoids were mechanically disrupted into single cells and plated in droplets of Cultrex growth factor reduced BME type 2 (Biotechne | R&D systems 3533-010-02). For the 2D culture of airway organoids ...
-
bioRxiv - Cancer Biology 2023Quote: Transparent PET membrane culture inserts of 24-well plate (Falcon, 353097) were coated with Cultrex Reduced Growth Factor Basement Membrane Extract (BME) (R&D Systems, 3533-010-02) at 50μg per membrane (200μl of 0.25mg/ml BME stock per membrane ...
-
bioRxiv - Developmental Biology 2024Quote: ... and cells were resuspended in 1 part Advanced DMEM/F12 and 2 parts Cultrex Reduced Growth Factor Basement Membrane Extract (R&D Systems; 3533-010-02) for a final solution of 66% Cultrex ...
-
bioRxiv - Immunology 2019Quote: ... Following an overnight culture islets were treated with 200 U/ml recombinant human (h) TNFα (R&D Systems) for 1 ...
-
bioRxiv - Immunology 2019Quote: ... and antibodies were obtained as follows: recombinant human VCAM-1 (#862-VC) from R&D Systems (Minneapolis, MN); recombinant human IL-2 from the NIH AIDS Reagent Program ...
-
bioRxiv - Genomics 2021Quote: ... medium supplemented with 100ng/mL recombinant human/mouse/rat activin A (R&D systems, cat. 338-AC-010) and incubated cells for 18 hours ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human PRDX6 (150 μg/mL final) and active MAPK (ERK2, R&D Systems, 10 μg/mL final) were added to 30 μL of a phosphorylation buffer containing 50 mM Tris/HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2022Quote: ... Microvessels with and without 24 h treatment with 5 ng mL-1 human recombinant TNFα (R&D Systems), were perfused with THP1s under low shear stress (∼0.2 dyne cm-2 ...
-
bioRxiv - Biophysics 2022Quote: ... followed by incubation with 0.01 mg/mL recombinant human VCAM-1/CD106 Fc chimera protein (R&D Systems) and 0.01 mg/mL ChromPure Human IgG ...
-
bioRxiv - Bioengineering 2022Quote: ... media in the top compartment was replaced with recombinant human TNFα (0.1 ng/mL, R&D Systems, 210TA) and recombinant human IFNγ (2 IU/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... the beads were introduced to either 20 nM recombinant human GAS6 (R&D Systems, Cat# 885-GSB-050), or recombinant human Protein S (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... then incubated with various concentrations (0 to 100 nM) of human recombinant tau (2N4R, R&D Systems Inc.) in the absence or presence of RAP (at a 20-fold molar excess compared to the concentration of tau ...
-
bioRxiv - Genomics 2019Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells were incubated for 8 hours prior to harvest ...
-
bioRxiv - Cell Biology 2022Quote: ... or Basal Medium plus 100 ng/ml recombinant human NTN1 (6419-N1, R&D Systems, Minneapolis, MI, USA). Photographs were taken after 4 h of incubation ...
-
bioRxiv - Biochemistry 2019Quote: ... These wells were suspended above wells containing 5 to 10 ng/mL recombinant human VEGF (R&D Systems) or full serum medium ...
-
bioRxiv - Cell Biology 2019Quote: ... Control medium was then augmented with 10 ng/mL recombinant human TGF-β1 (R&D Systems; chondrogenic media) to induce chondrogenesis ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human MFG-E8 protein produced in mouse myeloma cells was purchased from R&D Systems (Minneapolis, MN).
-
bioRxiv - Genomics 2020Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells incubated for 8 hours prior to harvest.
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: Control and Slc7a7-/- mice were intraperitoneally injected with recombinant human erythropoietin (500 U/kg/day; R&D Systems) daily for three consecutive days ...
-
bioRxiv - Cell Biology 2023Quote: ... EBs were formed in an ESC medium depleted of recombinant human FGF-2 (rhFGF-2) (R&D Systems) on day 0 ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were treated for 24h with 100ng/ml media of human recombinant GBA (rhGBA-His (R&D Systems)).
-
bioRxiv - Cancer Biology 2023Quote: ... C2C12 cells were treated with ZA in the presence or absence of recombinant human TGFβ1 (R&D Systems).